Arachidonate-containing oxidized phospholipids are acutely generated by 12-LOX (12-lipoxygenase) in agonist-activated platelets. In the present study, formation of structurally related lipids by oxidation of DHA (docosahexaenoic acid)-containing phospholipids is demonstrated using lipidomic approaches. Precursor scanning reverse-phase LC (liquid chromatography)-MS/MS (tandem MS) identified a new family of lipids that comprise phospholipid-esterified HDOHE (hydroxydocosahexaenoic acid). Two diacyl and two plasmalogen PEs (phosphatidylethanolamines) containing predominantly the 14-HDOHE positional isomer (18:0p/14-HDOHE-PE, 18:0a/14-HDOHE-PE, 16:0a/14-HDOHE-PE and 16:0p/14-HDOHE-PE) were structurally characterized using MS/MS and by comparison with biogenic standards.
INTRODUCTION
LOX (lipoxygenase), COX (cyclo-oxygenase) and CYP (cytochrome P450) enzymes oxidize non-esterified arachidonate to form eicosanoids, mediators that play important roles in both physiology and disease in virtually all organs. Several years ago, eicosanoid esterification, where the lipids become attached to phospholipids, was studied by addition of radiolabelled HETEs (hydroxyeicosatetraenoic acids) to cells followed by characterization of their fate by radio-TLC [1] [2] [3] [4] [5] [6] . In those studies, HETEs became esterified to phospholipids over periods of several hours and could be released by subsequent cell activation. Although phospholipid classes that contained HETE were determined, specific molecular species could not be identified. More recently, using lipidomic methods, we have found that acute activation of several immune cells, including monocytes, platelets and macrophages, leads to formation of distinct families of phospholipidesterified HETEs. The lipids form via LOX catalysis, within 2-5 min, in response to pathophysiological agonists and remain cell-associated suggesting an autocrine mode of action. This phenomenon is distinct from earlier work as the eicosanoids are endogenously generated and incorporation is acute, taking place over very short timeframes of 2-5 min. Each cell type generates 4-6 unique molecular structures, including diacyl and plasmalogen forms, belonging to either PE (phosphatidylethanolamine) or PC (phosphatidylcholine) classes. The positional isomers generated depend exclusively on the LOX isomer expressed. For example, IL (interleukin)-4-stimulated human monocytes and IL-13-stimulated human bronchial epithelial cells generate 15-HETE-PEs, whereas murine peritoneal macrophages and human platelets generate predominantly 12-HETE phospholipids [7] [8] [9] [10] .
To date, studies have concentrated on oxidized phospholipids that originate from arachidonate oxidation; lipids containing other unsaturated fatty acids have not been characterized. These could include linoleate and omega-3 species, such as DHA (docosahexaenoic acid), derived from fish oil. Given fish oil-derived fatty acids are reported to possess anti-platelet activities, the present study examined for the presence of analogues of oxidized phospholipid-containing monohydroxy forms of this lipid, HDOHE (hydroxydocosahexaenoic acid) generated by human platelets following acute activation with the pathophysiologically relevant agonist, thrombin.
washed by centrifuging at 800 g for 10 min then resuspended in Tyrode's buffer at a concentration of 2 × 10 8 cells per ml. Platelets were activated using 0.2 units/ml thrombin at 37
• C in the presence of 1 mM CaCl 2 for various times.
Lipid extraction
For quantification, 10 ng of 12-HETE-d 4 and/or DMPE (dimyristoyl-PE) was added before extraction. Lipids were extracted by adding a solvent mixture (1 M acetic acid/propan-2-ol/hexane; 2:20:30 by vol.) to the sample at a ratio of 2.5 ml of solvent mixture/ml sample, vortexing and then adding 2.5 ml of hexane [11] . After vortex and centrifugation (500 g for 5 min), lipids were recovered in the upper hexane layer. The samples were then re-extracted by addition of an equal volume of hexane. The combined hexane layers were dried and analysed for nonesterified or esterified HETEs using LC (liquid chromatography)-MS/MS (tandem MS), as described below. Inhibitors of calcium mobilization were added 10 min before activation
Precursor scanning MS
Lipid extracts were separated by reverse-phase HPLC using a Luna 3 μm C18 (2) 150 mm × 2 mm column (Phenomenex) with a gradient of 50-100 % B over 10 min followed by 30 min at 100 % B [A, methanol/acetonitrile/water (1 mM ammonium acetate) at a ratio 60:20:20; B, methanol and 1 mM ammonium acetate] with a flow rate of 200 μl·min −1 . MS was carried out using an Applied Biosystems 4000 Q-Trap. Settings were DP, − 140 V and CE − 45 V. Spectra were acquired scanning Q1 from 600-1100 amu (atomic mass unit) over 5 s with Q1 set to the daughter ion of interest.
Phospholipid separation and analysis by LC-MS/MS
Phospholipid separation was carried out as described for precursor scanning. Analytes were monitored in SRM or MRM (single/multiple reaction monitoring) modes using the parent carboxylate anion or internal daughter ion for specific positional isomers. Product ion spectra were obtained at the apex of elution of each lipid, with the MS operating in ion-trap mode. Scans were acquired over 0.65 s, with a linear ion-trap fill time of 200 ms and Q0 trapping.
Normal-phase HPLC-UV of phospholipid classes and HDOHE isomer determination
Fractionation of platelet lipid classes was undertaken on a Spherisorb S5W 150 × 4.6 mm column (Waters) with a gradient of 50-100 % B over 25 min (A, hexane/propan-2-ol at a ratio of 3:2; B, solvent A/water at a ratio of 94.5:5.5) at a flow rate of 1.5 ml·min −1 . Absorbance was monitored at 205 nm and lipids identified using a mixture of standard phospholipids (SigmaAldrich). Fractions corresponding to PE (approx. 6 min retention time) or PC (approx. 20 min retention time) were collected for subsequent analysis by ESI (electrospray ionization)-MS/MS. PE or PC lipids were then analysed for the m/z of interest using reverse-phase separation as described above. For determination of the HDOHE positional isomer composition in PE, the purified phospholipid fraction was saponified as described below, then resuspended in 50 μl of methanol, and HDOHE isomers analysed by reverse-phase LC-MS/MS as described below.
Saponification
Lipids were suspended in 1.5 ml of propan-2-ol, and then fatty acids were released by base hydrolysis with 1.5 ml of NaOH at 60
• C for 30 min under N 2 . Hydrolysed samples were acidified to pH 3.0 with 0.5 M HCl and fatty acids were extracted twice with 3 ml of hexane. The combined hexane layers were dried, resuspended in 100 μl of methanol and stored under N 2 at − 80
• C until analysis by LC-MS/MS. 
Oxidation of PE and PC using recombinant LOXs
At total of 10 mM brain L-α-PE (Avanti Polar Lipids), 18:0a/22:6-PC or -PE (Sigma-Aldrich) was incubated for 30 min at 37
• C in 0.1 M KH 2 PO 4 buffer, pH 7.4, 0.2 % sodium cholate, with 100 μl of I428A mutant rabbit 15-LOX, that oxidized primarily at C12 [12] . Samples were then reduced using 1 mM SnCl 2 for 10 min at 20
• C, and extracted as above for LC-MS/MS analysis. DHA or 18:0a/22:6-PE was incubated for 30 min at 37
• C in 0.1 M KH 2 PO 4 buffer, pH 7.4, 0.2 % sodium cholate, with 50 μl of recombinant human platelet 12-LOX. Samples were then reduced using 1 mM SnCl 2 for 10 min at 20
• C and extracted as for the LC-MS/MS analysis.
Quantification of HDOHE-PEs
Mixed isomer HDOHE-PE standards were generated using air oxidation, and purified using reverse-phase HPLC. A standard curve was constructed by analysing various (1 pg-10 ng on the column) amounts of standard with a fixed amount of DMPE (100 pg). The ratio of analyte/internal standard (integrated from chromatograms) was calculated and converted into the amount of HDOHE-PE using the standard curve. As platelets contain a mixture of positional isomers, total HDOHE-PE was determined using the m/z 343.2 daughter ion which quantifies all ten isomers as a single group.
RESULTS

Precursor LC-MS/MS scanning of platelet lipid extracts
To identify lipids that contain oxidized DHA, lipid extracts from thrombin-activated platelets were subject to precursor LC-MS/MS, which fragments using CID (collision-induceddissociation), and scans for a functional group of interest in Q3. With Q3 set at m/z 343.2 (i.e. the carboxylate anion of HDOHE), negative precursor LC-MS/MS demonstrates several ions that increase on activation ( Figure 1A , marked by *). Four major ions predominate, at m/z 762.6, 778.7, 790.6 and 806.7, and they are largely absent in unactivated platelets ( Figures 1A and 1B) . A fifth large ion was observed to elute after these lipids (at 27 min, m/z 818.6; marked by ** in Figure 1A ). Although this lipid appears to be a significant species in this Figure, it was only observed in approx. one-third of our donor pool isolates. Its m/z is consistent with two potential phospholipids, 18:0p/HDOHE-PC or 20:0p/HDOHE-PE. However, we were unable to assign it to either since the retention time is too late for a PC, and the unoxidized parent lipid 20:0p/22:6-PE is not detected in our cells in precursor scans for m/z 327, equivalent to DHA (m/z 802.6, see Figure 3C ). Thus we believe that neither is a likely candidate for this lipid. LC-MS/MS spectra were generated for this ion in both positive and negative mode (assuming that [M + H] + will be either 820 or 834 for PE or PC respectively). However, neither were consistent with the potential molecular species as listed above and, furthermore, due to its late retention time, unrelated ions from co-eluting isobaric species were also detected (results not shown). Thus we have been unable to structurally characterize this peak. Precursor scans for DHA (m/z 327.2) demonstrate four major lipids that are 18 amu less than those for the HDOHEcontaining ions shown in Figure 1(A) (Figure 1C ). This indicates that both DHA and HDOHE are generally contained within the same phospholipid pool in human platelets.
Structural characterization of esterified HDOHEs
Several approaches were utilized for elucidating the structure of the esterified HDOHEs marked by the * in Figure 1(A) . First, phospholipids were separated by class using normalphase LC. This was followed by reverse-phase LC-MS/MS to determine which phospholipid classes contained esterified HDOHE. Separately, platelet lipid extracts were compared with standards using LC-MS/MS. In this case, standards were generated by oxidation of DHA-containing phospholipids using a recombinant mutant rabbit 15-LOX, that oxidizes at C 12 of arachidonate and is capable of phospholipid oxidation [12] .
Normal-phase separation of phospholipid classes
To determine the phospholipid class for each ion, PEs and PCs was purified from thrombin-activated platelets and analysed for the presence of the four most abundant m/z 343.2-containing ions. All were detected in the PE but not the PC fraction, indicating that they all belong to this phospholipid class (Figure 2 ).
Structural determination of HDOHE-PEs using LC-MS/MS
The four predominant masses observed in precursor m/z 343.2 scans (Figure 1) were analysed using LC/MS/MS, monitoring for parent to m/z 343 [M − H] − . They elute as broad peaks from 20-25 min, suggesting they contain a mixture of positional isomers of HDOHE (Figures 3 and 4) . The abundance of platelet HDOHEcontaining lipids was below the limit of sensitivity for generation of online ion-trap MS/MS spectra. Thus structural assignment was made on the basis of comparison of MRM retention time with synthetic standards generated by oxidation of brain PE (that contains a high proportion of DHA) using a mutant rabbit 12-LOX (I418A). Unfortunately, for most of these lipids, purified substrates were unavailable at the time. As shown, the major ions for m/z 762.2, 778.6, 790.6 and 806.6 co-elute with standards for 16:0p/HDOHE-PE, 16:0a/HDOHE-PE, 18:0p/HDOHE-PE and 18:0a/HDOHE-PE respectively (Figures 3-5 Figures 3D and 4D, insets) . Finally, all show loss of the sn2 HDOHE (344 amu) at m/z 418, 434, 446 and 462 for m/z 762, 778, 790 and 806. They also demonstrate loss of the corresponding sn2 ketene at + 18 amu above these. In addition to HDOHE-PEs, platelet lipids analysed for m/z 790 and 806 showed fairly large ions eluting just after 26 min ( Figures 4A and 4C ). Although these also generate an m/z 343 daughter ion, they appear to elute too late to be HDOHE-PEs, and are uncharacterized isobaric lipids present in this complex extract.
Saponification and analysis of HDOHE positional isomers
To determine the positional isomer(s) of HDOHE contained in the lipids, total PE was isolated from activated platelet lipids by normal-phase HPLC and then saponified to release all HDOHE. The sample was then analysed using LC-MS/MS in comparison with standards. This showed that 14-HDOHE is the most abundant positional isomer contained in the PE phospholipids, with smaller amounts of 17-and 20-HDOHE ( Figure 6A ). This was similar to the isomer distribution of nonesterified HDOHE generated by thrombin-activated platelets, with 14-HDOHE also predominating ( Figure 6B ). We were unable to determine S/R enantiomers given standards are not available.
Studies using human recombinant platelet 12-LOX
To determine whether these lipids may be generated by platelet 12-LOX, human recombinant enzyme was incubated with DHA and formed primarily the 14-HDOHE positional isomer ( Figure 6C ). In contrast it did not oxidize either arachidonic acid or DHA when attached to PE (results not shown). This indicates that the enzyme does not directly oxidize phospholipids.
HDOHE-PEs are generated acutely, in a calcium-dependent manner and require hydrolysis of DHA Activation of platelets using 0.2 units/ml thrombin for various times showed that the lipids are generated in an acute manner, with elevations apparent by as early as 2 min, then continuing to slowly increase to at least 3 h ( Figure 7A ). Similar temporal increases were apparent for non-esterified HDOHE isomers, with 14-HDOHE predominating ( Figure 7B ). Separately, platelets were incubated with 10 ng of 14-HDOHE, then studied for formation of HDOHE-PEs (the other lipids not shown were present at low levels or undetected). To determine whether exogenously added HDOHE could be incorporated into these phospholipids, 10 ng of 14-HDOHE was incubated with platelets for up to 30 min. However, during this time, HDOHE-PEs were not observed to form, indicating that their generation A 2 ) or cPLA 2 (cytosolic phospholipase A 2 ), but not iPLA 2 (calcium-independent phospholipase A 2 ) (with the inhibitors OOEPC, cPLA 2 i or BEL respectively) ( Figures 8B and  8C ). These observations are consistent with the idea that HDOHE-PE formation requires hydrolysis of DHA and formation of non-esterified HDOHE before its esterification into phospholipid. 
DISCUSSION
In the present study, a novel family of oxidized phospholipid comprising HDOHE attached to PE was identified in thrombinactivated human platelets. This is the first demonstration of esterified oxidation products of DHA formed by an agonistactivated cell type, and represents a new family of oxidized phospholipid. We recently identified formation of esterified HETEs in human platelets and monocytes, and murine peritoneal macrophages, and showed that they form by the action of cellspecific LOXs [7, 8, 10] . HDOHE-PEs are a related but distinct family, containing instead oxidized DHA, a major fatty acid in fish oil.
In the present study, the predominance of esterified 14-HDOHE over other positional isomers suggests these lipids are also generated by platelet 12-LOX, similar to esterified HETEs ( Figure 6A ). In support, recombinant human 12-LOX formed primarily non-esterified 14-HDOHE from non-esterified DHA ( Figure 6C ). LOXs are a family of lipid-oxidizing enzymes expressed in mammals predominantly by immune cells and platelets [13] . They are traditionally known as a source of non-esterified eicosanoids, oxidizing arachidonate that has been released by PLA 2 , forming bioactive lipids including leukotrienes and HETEs. Thrombin-activated platelets also generated nonesterified 14-HDOHE from endogenous DHA, consistent with a previous report of this positional isomer being formed on incubation of exogenous DHA with platelets ( Figure 6B ) [14] . However, generation of non-esterified 14-HDOHE from endogenous platelet phospholipid-derived DHA has not been reported previously. Owing to limitations in amount of material and unavailability of enantiomerically pure standards, we were unable to determine the enantiomeric composition of either the non-esterified or esterified 14-HDOHE generated.
In platelets, HDOHE was esterified into PE, with four distinct molecular species detected (16:0p, 16:0a, 18:0p and 18:0a) ( Figure 5) . A further unidentified lipid was detected in extracts (A) Platelet-generated 18:0a/HDOHE-PE preferentially contains 14-HDOHE isomer. PE was purified from thrombin-activated platelets and separated using normal-phase LC, saponified, then HDOHE positional isomers in the saponified PE fraction characterized using LC-MS/MS as described in the Experimental. (B) 14-HDOHE is the predominant non-esterified acid isomer generated from activated platelets. Non-esterified HDOHE isomers were analysed using LC/MS/MS from extracts of human platelets activated with 0.2 units/ml thrombin. (C) Oxidation of DHA by recombinant platelet LOX generates the 14-HDOHE isomer. DHA was oxidized using recombinant human platelet 12-LOX as described in the Experimental section, then isomers were determined using LC-MS/MS. from a subset of donors at m/z 818.6. This distribution is different from platelet phospholipid-esterified HETEs, which comprise two PC and four PEs. In addition, HDOHE, but not HETE, is found attached to 16:0a-PE. The reason for selective generation of a 16:0a-PE species and absence of HDOHE-PCs may relate to the distribution of DHA compared with arachidonic-acid-containing parent phospholipids in the membrane. In support, precursor scans for m/z 327.2 (DHA carboxylate anion) show the same distribution of lipids as HDOHE (Figure 1 ). The inability of recombinant 12-LOX to oxidize DHA-containing PE suggests that the lipids (A) Time course of HDOHE-PE generation by thrombin-activated platelets. Platelets were activated using 0.2 units/ml thrombin for various times, then lipids were extracted and analysed using LC/MS/MS as described in the Experimental section. HDOHE-PEs were quantified by comparison with standard curves for HDOHE-PE comparesd with DMPE, conducted as described. (B) Time course of non-esterified HDOHE generation by thrombin-activated platelets. Platelets were activated using 0.2 units/ml thrombin for various times, then lipids extracted and analysed using LC/MS/MS as described in the Experimental section for 8-, 14-and 16-HDOHE. Other isomers were present at low levels or undetectable. (C) Exogenously added non-esterified HDOHE is not incorporated into phospholipids. Platelets were incubated with 10 ng of 14-HDOHE for 15 or 30 min at 37 • C before analysis for HDOHE-PE formation using LC-MS/MS. form via sequential PLA 2 hydrolysis of DHA-PE, followed by 12-LOX oxidation, then finally re-esterification of HDOHE into PE. This idea is further supported by the observation that inhibition of cPLA 2 blocks their generation, and is similar to the mechanism of HETE phosphospholipid formation proposed recently ( Figure 8B ) [10] . In an earlier study, we used a different cPLA 2 inhibitor (10 μM PACOCF3) and did not reveal a role for this isoform in formation of HETE phosphospholipids. However, we since found out that 10 μM was probably not sufficient for full inhibition (IC 50 for cPLA 2 and results not shown). Thus it is likely that hydrolysis of DHA or arachidonic acid for oxidation and re-esterification following oxidation does involve cPLA 2 . On the other hand, sPLA 2 may act in a different manner, for example through generation of lyso-PC that signals independently of fatty acid mobilization [16, 17] . Time course experiments showed that HDOHE-PE formation was fast, paralleling that of non-esterified HDOHE, and that it required calcium mobilization ( Figures 7A, 7B and 8A ) [10] . This is further consistent with a role for 12-LOX, which is known to be activated acutely in a calcium-dependent manner. Levels continued to rise, even up to 3 h post-activation, although in some donor isolates, a small decrease by later time points was noted and ascribed to donor variability (results not shown). Finally, added non-esterified 14-HDOHE was not incorporated into platelet phospholipids during this time scale ( Figure 7C ). This suggests a tight coupling of pathways that synthesize and esterify HDOHE, such that eicosanoid destined for export as nonesterified HDOHE is formed from a different pool.
HETE-PCs were recently found to promote tissue-factordependent thrombin generation in vitro suggesting a procoagulant role [10] . In contrast, omega-3 fatty acids from fish oil, including DHA, have long been suggested to possess antiplatelet activities [18] . Although studies have been somewhat contradictory, reported effects include inhibition of thrombus and vascular lesion formation in vivo [18, 19] . How fish-oil-derived fatty acids mediate these effects is unknown, but one proposed mechanism involves formation of omega-3-based prostaglandins by COX that may oppose the action of pro-aggregatory lipids generated from arachidonate. Our studies identify new DHAderived lipids that may also regulate coagulation through antagonizing the actions of HETE-PEs or through acting as a reservoir for non-esterified HDOHE. In this case, 14-HDOHE could be released by PLA 2 and then act as a free acid mediator to antagonize platelet activation and smooth muscle constriction, as shown previously [20, 21] . These ideas will be tested as soon as sufficient quantities of purified HDOHE-PEs become available.
Esterified eicosanoids and fatty acids belong to a class of molecule termed oxidized phospholipid, which includes hundreds of structures including decomposition products of phospholipid hydroperoxides that can act as scavenger receptor ligands [22] [23] [24] [25] . To date, this has been generally assumed to be an uncontrolled pathological event forming multiple bioactive lipids that play deleterious roles in vascular disease and inflammation. In contrast, we have shown in our recent study [10] , and in the present study, that it is triggered by acute agonist-receptor signalling in human platelets, resulting in generation of specific groups of molecular species. This present study further supports the idea that acute phospholipid oxidation by platelets is physiological and distinct to formation of non-esterified acid eicosanoids through formation of structurally distinct complex lipids.
